Rationale: Hyperhomocysteinemia is a cardiovascular risk factor that is associated with elevation of the nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA). Objective: Using mice transgenic for overexpression of the ADMA-hydrolyzing enzyme dimethylarginine dimethylaminohydrolase-1 (DDAH1), we tested the hypothesis that overexpression of DDAH1 protects from adverse structural and functional changes in cerebral arterioles in hyperhomocysteinemia. 
H yperhomocysteinemia is an independent risk factor for cardiovascular disease, ischemic stroke, and venous thromboembolism. 1, 2 Abnormal vasomotor function, altered vascular mechanics and morphology, and accelerated thrombosis have been observed in animal models of hyperhomocysteinemia. 3 Although there is strong epidemiological evidence that hyperhomocysteinemia is associated with an increased risk of adverse cardiovascular events, several large intervention trials have failed to demonstrate any clinical benefit of homocysteine-lowering therapy. 4 -9 The negative results of these trials may be related to inadequate sample size, confounding because of effects of folate fortification, or possible adverse effects of high dose B vitamins. 10 Another possible explanation is that hyperhomocysteinemia might be associated with increased cardiovascular risk because it is a marker of another causative risk factor. One candidate for such a factor is asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of NO synthase. 10 Dysregulation of ADMA metabolism may occur in hyperhomocysteinemia through an inhibitory effect of homocysteine on the expression and activity of dimethylarginine dimethylaminohydrolase (DDAH), which hydrolyzes ADMA to citrulline and dimethylamine. [11] [12] [13] Overexpression of the major isoform of DDAH, DDAH1, in transgenic mice has been shown to protect from the adverse vasomotor effects of exogenous ADMA on endothelial function. 14, 15 It is not known, however, if DDAH1 overexpression protects from the vascular consequences of hyperhomocysteinemia. Interestingly, DDAH also may influence vascular function through a mechanism that is independent of ADMA hydrolysis. 16, 17 The ADMA-independent cellular effects of DDAH are thought to involve direct binding of DDAH to cell signaling molecules such as protein kinase A or Ras pathway regulatory molecules. 18 The goal of the present study was to use DDAH1 transgenic mice to test the hypothesis that overexpression of DDAH1 protects from hyperhomocysteinemia-induced vascular dysfunction, vascular hypertrophy, and thrombosis. Our findings demonstrate that transgenic overexpression of DDAH1 does not protect mice with dietary hyperhomocysteinemia from endothelial dysfunction or accelerated thrombosis. In contrast, overexpression of DDAH1 does provide protection from the deleterious effects of hyperhomocysteinemia on vascular muscle function and the development of cerebral vascular hypertrophy. A lack of elevation of plasma ADMA in hyperhomocysteinemic mice suggests that these protective effects of DDAH1 may be independent of ADMA.
Methods

Mice and Experimental Diets
Animal protocols were approved by the University of Iowa and Veterans Affairs Animal Care and Use Committees. Human DDAH1 transgenic (DDAH Tg) mice 14 were generated on the C57BL/6 background and maintained by backcrossing to C57BL/6 mice. Genotyping was performed by polymerase chain reaction using the primers: 5Ј-AGCACCAGCTCTACGTG-3Ј (forward) and 5Ј-GCCCTTTGTT-GGGGATATT-3Ј (reverse). Starting from the time of weaning (3 to 4 weeks of age), mice were fed either a control diet (LM485, Harlan Teklad, Madison, Wis), which contains 6.7 mg/kg folic acid and 4.0 g/kg L-methionine, or a high methionine/low folate (HM/LF) diet (TD00205, Harlan Teklad) that contains 0.2 mg/kg folic acid and 8.2 g/kg of L-methionine. 19 Mice were maintained on the control or HM/LF diets until they were studied at 6 to 12 months of age.
Plasma Total Homocysteine, ADMA, and SDMA
Blood was collected by cardiac puncture into EDTA (final concentration 5 mmol/L). Plasma was separated by centrifugation, flash frozen, and stored at Ϫ80°C. Plasma total homocysteine (tHcy), defined as the total concentration of homocysteine after quantitative reductive cleavage of all disulfide bonds, 20 was measured by high performance liquid chromatography (HPLC) using ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate fluorescence detection. 21 Plasma and tissue levels of ADMA and SDMA were determined by HPLC using precolumn derivatization with o-phthaldialdehyde. 22 
Immunoblotting
Samples of aorta or carotid artery were homogenized in ice-cold HEMGN buffer (25 mmol/L HEPES [pH 7.6], 0.1 mmol/L EDTA, 12.5 mmol/L MgCl 2 , 100 mmol/L KCl, 10% glycerol [v/v], 0.1% NP-40 [v/v]) containing a protease inhibitor cocktail (Complete Mini EDTA-free, Roche Applied Science, Indianapolis, Ind). Homogenates were centrifuged at 14000g for 30 minutes at 4°C. Protein concentrations of supernatant fractions were determined using the Bradford protein assay (Bio-Rad Laboratories, Hercules, Calif). Samples (5 g protein) were separated by SDS-PAGE on 10% polyacrylamide gels, transferred to poly(vinylidene difluoride) membranes (Millipore, Billerica, Mass), and probed with 1 g/mL monoclonal antibody raised against rat DDAH1 23 for 2 hours at room temperature. This antibody cross-reacts with both murine and human DDAH1. 15 To control for sample loading, the membranes were reprobed with 0.5 g/mL anti-␤-actin monoclonal antibody (Abcam, Cambridge, Mass) for 2 hours at room temperature. Horseradish peroxidase-conjugated goat anti-mouse antibody (Pierce, Rockford, Ill) was used as the secondary antibody (10 ng/mL, 1 hour, RT). Immunoreactive bands were visualized using Supersignal West Femto (Pierce) detection system. Densitometry was performed on a Bio-Rad VersaDoc Imaging System equipped with the Quantity1 software program.
Vasomotor Function in Cerebral Arterioles
Dilation of cerebral arterioles was measured using a cranial window preparation as described previously. 24 Briefly, mice were anesthetized and ventilated mechanically with room air and supplemental oxygen, a cranial window was made over the left parietal cortex, and a segment of a randomly selected pial arteriole (Ϸ30 m in diameter) was exposed. Changes in the diameter of the cerebral arteriole were measured, using a video microscope coupled to an image-shearing device, during superfusion with acetylcholine (1 and 10 mol/L) and papaverine (1 and 10 mol/L).
Structure and Mechanics of Cerebral Arterioles
Systemic arterial blood pressure was measured in conscious mice using a carotid artery catheter as described previously. 25 Pressure and diameter in first order arterioles on the cerebrum were measured in anesthetized mice through an open skull preparation with a micropipette connected to a servo-null pressure-measuring device as described previously. 26 Arteriolar pressures and diameter were measured under baseline conditions and again after deactivation of vascular muscle by suffusion of cerebral vessels with artificial CSF containing EDTA as described previously. 26 After the animal was killed by an injection of potassium chloride, the arteriolar segment used for pressure-diameter measurements was removed, processed and embedded for microscopy in Spurr's low viscosity resin while maintaining cross-sectional orientation. The crosssectional area of the arteriolar wall was determined as described in the Online Data Supplement. Mechanical characteristics of cerebral arterioles (circumferential stress, circumferential strain and tangential elastic modulus) were calculated from measurements of cerebral arteriolar pressure, diameter and cross-sectional area using an approach we have described in detail previously. 26, 27 
Carotid Artery Thrombosis
Carotid artery thrombosis was induced by photochemical injury as described previously. 28 Mice were anesthetized with sodium pentobarbital (70 to 90 mg/kg intraperitoneally) and ventilated mechanically with room air and supplemental oxygen. The left femoral vein was cannulated for the administration of rose bengal. The right common carotid artery was dissected free and carotid artery blood flow was measured with a 0.5 PSB Doppler flow probe (Transonic Systems Inc, Ithaca, NY) and digital recording system (Gould Ponemah Physiology Platform version 3.33). To induce endothelial injury, the right common carotid artery was transilluminated continuously with a 1.5-mV, 540-nm green laser (Melles Griot, Carlsbad, Calif) from a distance of 6 cm, and rose bengal (35 mg/kg) was injected via a femoral vein catheter. Blood flow was monitored continuously for 90 minutes or until stable occlusion occurred, at which time the experiment was terminated. First occlusion was defined as the time at which blood flow first decreased to zero for Ն10 seconds, and stable occlusion was defined as the time at which blood flow remained absent for Ն10 minutes.
Statistical Analysis
Comparisons of effects of genotype and diet on plasma metabolites and vascular mechanics (arteriolar pressures, diameters, cross-sectional area, wall thickness, and slope of tangential elastic modulus versus stress) were performed by two-way analysis of variance (ANOVA) with the Holm-Sidak post hoc test for multiple comparisons. Responses of cerebral arterioles to vasodilators were analyzed using two-way repeated measures ANOVA with Holm-Sidak post hoc analysis. Effects of genotype and diet on carotid artery thrombosis were analyzed using the Mann-Whitney rank sum test and Kaplan-Meier survival analysis with log-rank testing. Statistical significance was defined as a probability value Ͻ0.05. Values are reported as meansϮSE. 
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Results
Plasma tHcy and ADMA in DDAH1 Transgenic Mice
To determine whether overexpression of DDAH1 can protect from deleterious vascular effects of homocysteine in vivo, we used a HM/LF diet to induce dietary hyperhomocysteinemia in DDAH1 Tg mice and wild-type littermates. Plasma tHcy was elevated approximately 3-fold in both wild-type and DDAH1 Tg mice fed the HM/LF diet compared with the control diet (PϽ0.001) ( Figure 1A ). Plasma tHcy did not differ between wild-type and DDAH1 Tg mice. Plasma ADMA was similar in wild-type mice fed the control (0.29Ϯ0.02 mol/L) and HM/LF (0.30Ϯ0.02 mol/L) diets ( Figure 1B ), but was approximately 40% lower in DDAH1 Tg mice fed either diet (PϽ0.001) ( Figure 1B ). There were no statistically significant differences in SDMA levels between the groups (data not shown).
Expression of DDAH1 in Aorta and Carotid Arteries
Expression of DDAH1 protein was detected by immunoblotting in both the aorta and carotid artery of DDAH1 Tg mice ( Figure  2 ). No expression of DDAH1 protein was detected in the aorta or carotid artery of wild-type mice. The expression of DDAH1 was not significantly affected by the dietary intervention (Pϭ0.14).
Vascular Function in Cerebral Arterioles
Dilation of cerebral arterioles in response to the endotheliumdependent dilator, acetylcholine, was impaired in wild-type mice fed the HM/LF diet compared with the control diet ( Figure 3A) . A similar degree of impairment in dilator responses to acetylcholine was seen in DDAH1 Tg mice fed the HM/LF diet compared with the control diet ( Figure 3B ). Compared with the control diet, the HM/LF diet diminished dilator responses to 10 mol/L acetylcholine by 60% in wild-type mice (12Ϯ2 versus 29Ϯ3%; PϽ0.001) and 50% in DDAH1 Tg (14Ϯ3 versus 28Ϯ2%; PϽ0.001).
Cerebral arteriole responses to the direct smooth muscle agonist, papaverine ( Figure 3C and 3D) were also similar between wild-type and DDAH1 Tg mice fed the control diet. However, responses to the highest doses of papaverine (10 mol/L) were lower in wild-type mice fed the HM/LF diet than in wild-type mice fed the control diet (30Ϯ3 versus 45Ϯ5%; PϽ0.05). Responses to papaverine did not differ between the control diet and the HM/LF diet in DDAH1 Tg mice ( Figure 3D and 3F ).
Morphological and Mechanical Properties of Cerebral Arterioles
The relative preservation of responses to the endotheliumindependent vasodilator papaverine in DDAH1 Tg mice fed the HM/LF diet suggested a possible protective effect of DDAH1 on the structural mechanics of the vessel wall. To determine whether overexpression of DDAH1 protects from hyperhomocysteinemia-induced alterations in cerebral arteriole structure and elasticity, 26 wild-type and DDAH1 Tg mice were fed the control or HM/LF diets for 8 to 12 months. Systemic arterial mean pressure did not differ between groups of mice in either the unanesthetized or anesthetized states (Table) . Cerebral arteriolar pressures and diameters also did not differ significantly between groups of anesthetized mice (Table) . The crosssectional area of the vessel wall was significantly increased in cerebral arterioles of wild-type mice fed the HM/LF diet compared with the control diet (Table and Figure 4A ). Wall thickness was also significantly increased in these mice (Table and Figure 4B ). In striking contrast, no increases in crosssectional area or wall thickness were observed in DDAH1 Tg mice fed the HM/LF diet compared with the control diet. The slope of tangential elastic modulus versus stress was decreased (Table) and stress-strain curves were shifted to the right ( Figure  4C ) in cerebral arterioles of wild-type mice fed the HM/LF diet compared with the control diet (Table) . These results, which reflect an increase in passive distensibility, are consistent with previous findings in cerebral arterioles of hyperhomocysteinemic mice. 26 Interestingly, the stress-strain curves of the cerebral arterioles of DDAH1 Tg mice did not differ between the control and HM/LF diets ( Figure 4D ). The slope of tangential elastic modulus and stress in both groups of DDAH1 Tg mice was significantly higher than that in wild-type mice fed the HM/LF diet (Table) .
Carotid Artery Thrombosis
Susceptibility to carotid artery thrombosis was assessed using a photochemical injury method. 28 The mean times to first occlusion or stable occlusion did not differ significantly between wild-type and DDAH1 Tg mice fed the control diet ( Figure 5A ). The HM/LF diet caused a 60% to 70% shortening of the mean times to first occlusion and stable occlusion independently of genotype. Kaplan-Meier survival analysis demonstrated significant differences in carotid artery patency, defined as absence of stable occlusion, between mice fed the control and HM/LF diets (PϽ0.05 for either genotype), but no significant differences in patency between wild-type and DDAH1 Tg mice ( Figure 5B ).
Discussion
The main objective of this study was to test the hypothesis that overexpression of DDAH1 protects from the adverse vascular effects of hyperhomocysteinemia. There were 2 major findings from this study. (1) Contrary to our hypothesis, we found that overexpression of DDAH1 did not protect from hyperhomocysteinemia-induced endothelial dysfunction or thrombosis despite causing a significant lowering of plasma ADMA. These findings suggest that, at least in this model, hyperhomocysteinemia impairs vascular endothelial function through a mechanism that is largely independent of the ADMA/ DDAH pathway. It is more likely, therefore, that hyperhomocysteinemia produces endothelial dysfunction through alternative mechanisms, such as inhibition of endothelial NO synthase activity by protein kinase C 29 or oxidative inactivation of NO caused by an impairment in cellular antioxidant enzyme activity. 30 (2) Although DDAH1 Tg mice were not protected from hyperhomocysteinemia-induced endothelial dysfunction, they did exhibit resistance to impairment of vascular responses to the endothelium-independent agonist papaverine and to alterations in cerebral vascular wall structure and mechanics. These findings suggest that DDAH1 selectively protects from the deleterious effects of hyperhomocysteinemia on vascular muscle. The lack of elevation of plasma ADMA in hyperhomocysteinemic mice suggests that these protective effects of DDAH1 may be independent of ADMA.
One potential limitation of our study is that the HM/LF diet did not cause an elevation of plasma ADMA. Similar observations have been made in other murine models of hyperhomocysteinemia, 13, 29 raising the possibility that metabolic interac- tions between homocysteine and ADMA may differ in mice and humans. Even in humans, however, some recent studies have demonstrated that hyperhomocysteinemia is not always accompanied by elevation of plasma ADMA. 31, 32 It is possible that ADMA may accumulate intracellularly and inhibit vascular function even in the absence of elevation of plasma ADMA, because ADMA is actively taken up by vascular cells. 33 Another intriguing possibility is that the protective effects of DDAH1 overexpression that we observed may be ADMA-independent. Both DDAH1 and DDAH2 have been proposed to have effects on vascular cells that are independent of ADMA hydrolysis. 16, 17, 34 Future studies with catalytically-inactive variants of DDAH could be designed to address the role of the ADMAindependent effects of DDAH in the regulation of vascular function.
In agreement with previous studies of diet-induced hyperhomocysteinemia in mice, 19 plasma levels of tHcy were Ϸ3-fold higher in both wild-type and DDAH1 Tg mice fed the HM/LF diet compared with mice fed the control diet. Because hyperhomocysteinemia can lead to a decrease in the expression and activity of endogenous DDAH1, 11, 13 it was essential to demonstrate that the HM/LF diet did not alter the expression or activity of the DDAH1 transgene. Immunoblotting showed that expression of the human DDAH1 transgene under the control of the ␤-actin promotor was not significantly affected by the HM/LF diet, and overexpression of the DDAH1 transgene lowered plasma ADMA to a similar extent in DDAH1 Tg mice fed the control and HM/LF diets. These findings suggest that the expression and activity of the transgene was similar in normohomocysteinemic and hyperhomocysteinemic mice.
Several previous studies by our group and others have demonstrated that hyperhomocysteinemic animals have impaired vasomotor responses to endothelium-dependent dilators. 35 In some animal models, including the primate model in which we first demonstrated vasomotor dysfunction in mild hyperhomocysteinemia, 36 impaired responses to endotheliumindependent vasodilators also have been observed. In murine models of hyperhomocysteinemia, responses to endotheliumdependent dilators first become impaired in young mice (less than 6 months of age). 35 In older mice (greater than 6 months of age), impaired responses to both endothelium-dependent dilators and endothelium-independent dilators are often observed. 37 The present results, in which the HM/LF diet produced impairment of responses in cerebral arterioles to papaverine in wild-type mice aged 6 to 12 months (Figure 3 ), are consistent with these previous findings.
One potential mechanism of hyperhomocysteinemia-induced smooth muscle dysfunction is cerebral vascular hypertrophy, 26 which can lead to impairment in maximal vasodilator capacity. 38 To test the hypothesis that overexpression of DDAH1 protects from hyperhomocysteinemia-induced structural changes in vascular wall, we examined the wall thickness and cross-sectional area of cerebral arterioles in DDAH1 transgenic mice fed either the control or the HM/LF diet. Consistent with our previous observations, 26 hyperhomocysteinemia induced hypertrophic changes in the arterial wall, with significant increases in both wall thickness and cross-sectional area (Figure 4) . Like the effects of hyperhomocysteinemia on endothelium-independent vasomotor responses, vascular hypertrophy was prevented by overexpression of the DDAH1 transgene. It is very possible, therefore, that structural changes in the vessel wall are at least partially responsible for the observed impairment in response to papaverine.
Because the HM/LF diet did not elevate plasma ADMA, it is possible that the protective effect of DDAH1 on smooth muscle structure and function is independent of ADMA. One potential mechanism for this protective effect is the DDAH1-dependent phosphorylation of neurofibromin 1. 34 Neurofibromin 1 has been shown to regulate smooth muscle proliferation, 39 so modulation of neurofibromin 1 activity by DDAH1 could potentially Measurements of internal diameter prior to maximal dilatation of cerebral arterioles were obtained at prevailing levels of arterial pressure. Measurements of internal diameter after maximal dilatation were made at an arteriolar mean pressure of 40 mm Hg. Values of external diameter after maximal dilatation were calculated from measurements of internal diameter at 40 mm Hg arteriolar pressure and histological measurements of cross-sectional area of the vessel wall. E T vs stress indicates slope of tangential elastic modulus (E T ) vs stress. Values are meansϮSEM. *PϽ0.05 vs wild-type mice fed the control diet; †PϽ0.05 vs wild-type mice fed the HM/LF diet.
affect vascular wall structure and function. Another possible mechanism is that, despite the lack of elevation of plasma ADMA, hyperhomocysteinemia may promote the accumulation of intracellular ADMA in vascular cells. 33 If this is the case, then the protective effects of DDAH1 could be mediated by increased metabolism of this intracellular pool of ADMA. By decreasing intracellular levels of ADMA, DDAH1 may prevent angiotensin II-mediated smooth muscle hypertrophy, 40 perhaps leading to improved smooth muscle vasodilatory function. This potential mechanism is supported by the observation that the angiotensin II type 1 receptor antagonist valsartan protects from hyperhomocysteinemia-induced ventricular hypertrophy and vascular remodeling. 41, 42 We also observed that DDAH1 overexpression altered the changes in vessel wall elasticity induced by the hyperhomocysteinemic diet. As expected, 26 mice fed the HM/LF diet for 8 to 12 months exhibited increased passive distensibility of cerebral arterioles compared with control mice ( Figure 4C ). This difference between the HM/LF and control diets was not observed in DDAH1 Tg mice ( Figure 4D) . Interestingly, the elasticity of cerebral arterioles in DDAH1 Tg mice appeared to be intermediate between that of wild-type mice fed the control diet and wild-type mice fed the HM/FL diet (demonstrated by the differences in the slope of E T versus Stress shown in the Table) .
Finally, we tested the hypothesis that overexpression of DDAH1 protects from hyperhomocysteinemia-induced acceleration of thrombosis. We observed accelerated thrombosis in wild-type mice fed the HM/LF diet ( Figure 5A and 5B), but overexpression of DDAH1 did not protect from accelerated thrombosis caused by hyperhomocysteinemia. This finding indicates that, at least in this animal model, hyperhomocysteinemia likely causes accelerated thrombosis via an ADMAindependent mechanism. Our results are consistent with our previous observations that deficiency of endothelial NO synthase (Nos3) in mice does not lead to accelerated thrombosis. 43 Taken together, these studies suggest that deficient NO production is not a major mechanism for enhancement of thrombosis in carotid arteries in hyperhomocysteinemia. Possible alternative mechanisms of the prothrombotic effects of hyperhomocysteinemia include decreased tissue plasminogen activator binding to annexin A2, upregulation of tissue factor, or hyperactivation of platelets. 3 
